PTAR1

PTAR1 is the α-subunit of GGTase-III (GGTase3), a prenyltransferase complex assembled with the catalytic β-subunit of RabGGTase (RabGGTB) that geranylgeranylates a small set of specific substrates and thereby governs Golgi organization and membrane trafficking (PMID:31209342, PMID:32128853). One substrate is the Golgi SNARE Ykt6: GGTase-III geranylgeranylates Ykt6 at Cys194 following prior FTase-mediated farnesylation of Cys195, producing a doubly prenylated Ykt6, and crystal structures of the GGTase-III–Ykt6 complex define the structural basis for this second prenylation (PMID:32128853, PMID:39806148). Loss of PTAR1 leaves Ykt6 only singly farnesylated, impairing Golgi SNARE complex assembly, disorganizing Golgi morphology, and delaying intra-Golgi trafficking (PMID:32128853); downstream, lysosomal hydrolases such as cathepsin D and β-hexosaminidase are missorted and secreted, hydrolase maturation is disturbed, and LC3B accumulates, marking defective autophagy/lysosomal degradation (PMID:33035318). The second characterized substrate is the F-box protein FBXL2: GGTase-III geranylgeranylates FBXL2 to drive its membrane localization, and the crystal structure of the GGTase3–FBXL2–SKP1 complex shows an extensive interface between FBXL2's leucine-rich-repeat domain and PTAR1 that dictates substrate specificity even though FBXL2's CaaX motif is predicted to be a GGTase1 substrate (PMID:31209342). Consistent with its role in Golgi/glycosylation homeostasis, PTAR1 disruption alters Golgi morphology, lowers cell-surface heparan sulfate, and confers resistance to Rift Valley fever virus (PMID:26581979), and PTAR1 knockdown attenuates glucose- and KCl-stimulated insulin secretion in pancreatic β-cells (PMID:40598917).

1. 2015 Medium

   Before any enzymatic role was known, an unbiased genetic screen implicated PTAR1 in Golgi function by linking its loss to glycosylation defects and viral resistance.

   Evidence Haploid insertional-mutagenesis screen with heparan sulfate flow cytometry and Rift Valley fever virus infection assays

   PMID:26581979

   Open questions at the time

   • Golgi/glycosylation phenotype was inferred, not mechanistically dissected
   • No enzymatic activity or substrate identified at this stage
   • Connection to a prenyltransferase complex not yet established
2. 2019 High

   Established PTAR1 as the α-subunit of a novel prenyltransferase (GGTase3) by reconstituting its activity and solving its structure, answering what PTAR1 does biochemically and how it achieves substrate selectivity.

   Evidence Co-IP, in vitro prenylation assay, and crystal structure of the GGTase3–FBXL2–SKP1 complex with membrane-localization assays

   PMID:31209342

   Open questions at the time

   • FBXL2 ubiquitylation targets downstream of membrane localization not enumerated here
   • Whether other LRR/CaaX proteins are substrates left open
3. 2020 High

   Identified the Golgi SNARE Ykt6 as a GGTase-III substrate and showed PTAR1 catalyzes a second prenylation (Cys194 geranylgeranylation after Cys195 farnesylation), explaining how PTAR1 controls Golgi architecture.

   Evidence Biotinylated geranylgeranyl analogue substrate ID, GGTase-III–Ykt6 crystal structure, and PTAR1 KO Golgi morphology, trafficking, and SNARE assembly assays

   PMID:32128853

   Open questions at the time

   • Did not extend to lysosomal/autophagy consequences
   • Full substrate repertoire of GGTase-III beyond Ykt6 and FBXL2 unknown
4. 2021 Medium

   Connected PTAR1/double-prenylated Ykt6 to lysosomal homeostasis by showing acid hydrolases are missorted and autophagy is impaired in its absence.

   Evidence PTAR1 KO cells with cathepsin D and β-hexosaminidase secretion assays, hydrolase maturation Westerns, and LC3B immunoblotting

   PMID:33035318

   Open questions at the time

   • Single lab; mechanism downstream of Ykt6 prenylation not fully resolved
   • Direct causality versus general Golgi disruption not separated
5. 2025 Medium

   Confirmed Ykt6 Cys194 as the direct GGTase-III substrate and established the sequential FTase-then-GGTase-III prenylation order using analogue labeling.

   Evidence Biotin-labeled geranyl pyrophosphate analogue in vitro prenylation with site-specific cysteine identification

   PMID:39806148

   Open questions at the time

   • Methodological/confirmatory; no new substrates
   • Single lab
6. 2025 Medium

   Extended PTAR1 function to physiology by showing GGTase-III is required for glucose-stimulated insulin secretion in β-cells.

   Evidence siRNA knockdown of PTAR1 in INS-1 832/13 cells with insulin ELISA and Western blotting

   PMID:40598917

   Open questions at the time

   • Partial (~50%) knockdown; no rescue
   • Molecular mechanism linking GGTase-III to secretion beyond the Ykt6 connection not defined
   • In vivo relevance untested

• The full substrate repertoire of GGTase-III beyond Ykt6 and FBXL2, and the precise mechanistic link between GGTase-III activity and insulin secretion, remain to be defined.
• No comprehensive substrate census reported
• Mechanism connecting PTAR1 to β-cell secretion undefined
• No in vivo / disease-mutation evidence in the corpus